Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Customer.Support@LSBio.com - To submit questions about existing orders, pricing, availability,
bulk quotes, proforma invoice requests, or other billing issues.
Technical.Support@LSBio.com - To request technical information requests about an LSBio product
or its application.
Sales@LSBio.com - To request information about fee-for-service contract IHC studies, IHC reports, distribution
agreements, or general business development.
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
NTRK3 / TRKC is a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation and may play a role in the development of proprioceptive neurons that sense body position. Mutations in this gene have been associated with medulloblastomas, secretory breast carcinomas and other cancers.
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of ovary tissue using anti-NTRK3 mouse monoclonal antibody. (Dilution 1:50).
Immunohistochemistry
Immunohistochemical staining of paraffin-embedded Carcinoma of bladder tissue using anti-NTRK3 mouse monoclonal antibody. (Dilution 1:50).
Immunohistochemistry
Immunohistochemical staining of paraffin-embedded Carcinoma of pancreas tissue using anti-NTRK3 mouse monoclonal antibody. (Dilution 1:50).
Immunohistochemistry
Immunohistochemical staining of paraffin-embedded Carcinoma of prostate tissue using anti-NTRK3 mouse monoclonal antibody. (Dilution 1:50).
Immunohistochemistry
Immunohistochemical staining of paraffin-embedded Carcinoma of thyroid tissue using anti-NTRK3 mouse monoclonal antibody. (Dilution 1:50).
Immunohistochemistry
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of breast tissue using anti-NTRK3 mouse monoclonal antibody. (Dilution 1:50).
Immunohistochemistry
Immunohistochemical staining of paraffin-embedded Carcinoma of lung tissue using anti-NTRK3 mouse monoclonal antibody. (Dilution 1:50).
Immunohistochemistry
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of colon tissue using anti-NTRK3 mouse monoclonal antibody. (Dilution 1:50).
Immunohistochemistry
Immunohistochemical staining of paraffin-embedded Carcinoma of liver tissue using anti-NTRK3 mouse monoclonal antibody. (Dilution 1:50).
Immunohistochemistry
Immunohistochemical staining of paraffin-embedded Carcinoma of kidney tissue using anti-NTRK3 mouse monoclonal antibody. (Dilution 1:50).
Immunofluorescence
Anti-NTRK3 mouse monoclonal antibody immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY NTRK3.
Western blot
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NTRK3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NTRK3.